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Abstract
SHB (Src homology 2 domain-containing adapter protein B) is involved in receptor tyrosine kinase signaling. Mice deficient
in the Shb gene have been found to exhibit a transmission ratio distortion with respect to inheritance of the Shb null allele
among offspring and this phenomenon was linked to female gamete production. Consequently, we postulated that Shb
plays a role for oocyte biology and thus decided to investigate oocyte formation, meiotic maturation, and early embryo
development in relation to absence of the Shb gene. Oogenesis was apparently accelerated judging from the stages of
oocyte development on fetal day 18.5 and one week postnatally in Shb 2/2 mice; but in adulthood ovarian follicle
maturation was impaired in these mice. Completion of meiosis I (first polar body extrusion) was less synchronized, with a
fraction of oocytes showing premature polar body extrusion in the absence of Shb. In vitro fertilization of mature oocytes
isolated from Shb +/+, +/2 and 2/2 mice revealed impaired early embryo development in the 2/2 embryos. Moreover, the
absence of Shb enhanced ERK (extracellular-signal regulated kinase) and RSK (ribosomal S6 kinase) signaling in oocytes and
these effects were paralleled by an increased ribosomal protein S6 phosphorylation and activation. It is concluded that SHB
regulates normal oocyte and follicle development and that perturbation of SHB signaling causes defective meiosis I and
early embryo development.
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Introduction
Understanding the processes regulating oocyte maturation is a
topic of potential importance for assisted reproductive technology
for treating infertility as well as in understanding molecular
foundations of oocyte biology and pathology. The influence of
external hormonal factors as well as the intricate interplay between
oocytes and the surrounding somatic follicle cells have been
extensively investigated, though many details of the regulation of
these processes remain elusive. The challenge for discovering
control mechanisms lies in the difficulty of investigating the
cumulus-oocyte complex which is a developmental unit, implying
that oocytes in isolation do not faithfully reflect biology in situ.
Targeted gene deletion provides an excellent strategy for
studying follicle biology and creating models of human reproduc-
tive disorders [1,2]. Knocking out genes coding for hormones and
paracrine factors has been particularly successful. For example
mutations of genes encoding growth-differentiation factor 9 and
bone morphogenic protein 15 [3,4,5,6] have revealed that they
serve as oocyte secreted paracrine factors operating in concert with
steroids and follicle-stimulating hormone (FSH) to stimulate
granulosa cell growth and differentiation. Another example is
the phosphoinositide-39-phosphate phosphatase, PTEN (phospha-
tase and tensin homolog deleted on chromosome ten), which
regulates follicular activation and in whose absence oocyte growth
is prematurely activated leading to premature ovarian failure [7].
SHB (Src homology 2 domain-containing adapter protein B) is a
ubiquitously expressed SH2-domain adapter protein that has not
previously been investigated for a role in oocyte maturation. It is
involved in receptor tyrosine kinase signaling in many tissues by
generating signaling complexes in response to receptor activation
[8,9]. Furthermore, SHB has been found to interfere with the
actions of the ubiquitin ligase atrophin-interacting protein 4 (AIP4)
[10]. SHB has pleiotropic effects and the responses that it
transduces depend on both the stimulatory factor and the cell type
in which SHB signaling is active. It participates in the regulation of
apoptosis, cytoskeletal physiology, proliferation and differentiation
[8,11,12,13]. Embryonic stem cells deficient in Shb showed altered
patterns of differentiation in both mesodermal and endodermal
lineages [11,12,14,15].
A Shb gene knockout mouse was recently generated both on a
mixed genetic background (FVB/J-C57Bl/6-129Sv) and in
C57Bl/6 mice for studying its role in vivo [16]. Although
heterozygotes were viable, Shb 2/2 embryos and mice could
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genetic background, and consequently, the Shb knockout is fertile
only in the latter case. Interestingly, there was a transmission ratio
distortion because the Shb null allele was preferentially transmitted
from Shb +/2 mothers. Additionally, there was relative loss of
Shb 2/2 embryos that could have arisen at implantation or from
embryo resorption and severe developmental anomalies. Postna-
tally, aberrations were observed in Shb knockout mice, including
defective angiogenesis [17], impaired glucose homeostasis [18] and
diminished beta cell stress responses [19]. We hypothesized that
the transmission ratio distortion of the Shb null allele reflected
abnormalities in oocyte maturation, for which we found evidence
in the present study of Shb deficient mice.
Results
Oocyte/follicle morphology in late fetal, post-natal and
adult ovaries
The previously observed transmission ratio distortion and the
embryonic malformations in offspring from Shb +/2 or 2/2 mice
raise the possibilities that oocyte development and/or function are
altered in this mutant. Oocytes enter meiosis I during late fetal
development (around 18.5 dpc in the mouse) and form primordial
follicles together with somatic cells around birth. A few of these
develop to become primary follicles at one week after birth.
Follicle maturation further progresses by development to antral
follicles when the female mouse reaches a reproductive age, of
which a few ovulate in each estrous cycle. Consequently, we
decided to study oocyte/follicle morphology at these stages of
ovarian development in relation to the Shb gene mutant classifying
germ cells into primary oocytes, primordial follicles, primary
follicles and antral follicles according to the shape and number of
layers of somatic cells surrounding the oocytes.
There was a significant increase compared to wild-type controls
in the number of oocytes in Shb 2/2 fetuses at 18.5 dpc (Fig. 1).
Most wild-type oocytes were, as expected at this age, at the
pachytene stage of meiosis I. The lower panel of Fig. 1 shows an
increased ratio of diplotene to pachytene oocytes in Shb 2/2
ovaries, with heterozygotes intermediate between them and
controls. These findings led to the study of organotypic cultures
of ovaries at the same ages to isolate oogenesis from systemic
effects that may differ according to the genotype. The conditions
of culture did not fully reproduce the physiological in vivo
maturation process because fewer germ cells survived, yet the
degree of organ differentiation was similar after a week. There was
a significant increase in number of follicles at all stages in Shb2/2
ovaries compared to wild-type which amounted to several fold at
primordial and even secondary stages (Fig. 2).
In line with the increased number of oocytes in 18.5 dpc fetuses,
the number of primordial follicles was higher in Shb +/2 and 2/2
ovaries at one week of age compared to wild-type mice (Fig. 3),
although the subsequent rate of disappearance appeared to be
increased in the Shb +/2 ovaries as suggested by the fact that at
12 weeks they had the least number of follicles. Primary follicles,
the first stage of follicle growth, were more abundant in Shb 2/2
ovaries at week 1 (Fig. 1), but this was the only stage at which
growing follicles (primary and antral) were elevated compared to
the other two genotypes. The difference was revealed more
strikingly when the data were expressed as ratios of primary or
antral to primordial stages at weeks 6 and 12 when they were
significantly lower in the knockout (Supporting Fig. S1). The
ovarian weights at weeks 1 and 6 corresponded to the relative
number of growing follicles estimated in tissue sections without
exhibiting any direct relationship to body weight, although
Shb 2/2 mice were heavier than the other genotypes at week 1
(Supporting Table S1).
Taken together, the data in Figs. 1–3 suggest that absence of Shb
promotes early (pre- and post-natal) oocyte development whereas
that at reproductive ages is retarded.
Mature oocyte analyses
Mammalian oocytes remain at prophase of meiosis I from late
embryonic stages until ovulation, when meiosis resumes. Resump-
tion of meiosis and progression to metaphase I is characterized by
germinal vesicle breakdown (GVBD), chromosome condensation
and segregation, and is then followed by extrusion of the first polar
body. It seemed appropriate to study the effect of the Shb gene on
these events as well since the Shb-dependent effects on reproduc-
tion could result from events occurring at this stage of oocyte
development. As an indicator of whether SHB has an effect on the
timing of oocyte maturation around ovulation, first polar body
extrusion and its degeneration were assessed at 14 and 24 h after
superovulation. While the percentages of oocytes containing polar
bodies that could be detected (total fresh plus degenerated) at 14 h
were similar in the three groups of Shb oocytes (Fig. 4), Shb +/2
and Shb 2/2 oocytes had significantly more degenerated polar
bodies compared to wild-type controls, although the difference
disappeared at 24 h. These results suggest less synchronized
completion of meiosis I with a fraction of oocytes displaying
accelerated resumption of meiosis as a consequence of Shb
inactivation.
To obtain a time-course of oocyte maturation following PMSG
injection, oocytes were mechanically released and cultured for
different time periods. The number of GV oocytes that were
recovered with this procedure at 42 h after PMSG injection from
2 to 4 month-old ovaries was significantly lower in Shb 2/2 mice
than controls (Fig. 5A). This result was comparable to counts of
antral follicles in the ovaries of corresponding genotypes at the
same age (Fig. 3). When the oocytes were cultured for 2 hours
(corresponding to 44 h after PMSG injection), Shb 2/2 oocytes
had an increased prevalence of polar body extrusion (Fig. 5B)
compared to controls, this observation being in line with what was
observed at 14 h in the superovulation study (Fig. 4). The
difference in polar body extrusion disappeared at later time points
and this is also in agreement with the findings in Fig. 4 at 24 h
after hCG injection.
To directly determine whether SHB had any effect on
resumption of meiosis in oocytes, we examined the rates of GV
(germinal vesicle) and GV breakdown (GVBD) in oocytes isolated
from ovaries after PMSG treatment. Results are shown in Fig. 5C-
D. At 8 h of culture (50 h after PMSG injection), we detected
significantly more oocytes at the GV stage and fewer oocytes with
GVBD in Shb knockouts than in controls. Karyotyping oocytes at
the GVBD-stage revealed condensation of chromosomes at
meiotic metaphase I. Fig. 5E-F display the results of karyotyping,
in which in half of the chromosomes were in pre-metaphase I in
Shb knockout oocytes. The combined results in Figs. 4–5 indicate
reduced meiotic synchronization of Shb knockout oocytes with a
certain fraction of oocytes showing accelerated meiosis I and
others exhibiting a delayed response.
In vitro fertilization (IVF) and blastocyst morphology
The effect of Shb deficiency on early embryo development was
studied after in vitro fertilization and in blastocysts retrieved from
pregnant mice at 3.5 dpc since an altered oocyte maturation
before and after ovulation could have an effect on these processes.
Oocytes were scored for degeneration or successive stages of
development to the morula (Fig. 6) after a culture time of 24 h that
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developed to the morula stage was lower than expected and this
may be due to the mixed genetic background currently used
compared with the F1(C56Bl/6xA2G) background normally
adopted for IVF studies. Significantly fewer oocytes reached the
morula developmental stage from fertilized Shb 2/2 oocytes
compared to wild-type controls. In addition, significantly more Shb
knockout oocytes degenerated after the 24 h culture period. The
numbers of oocytes that showed no signs of degeneration or
mitosis were similar in the +/+, +/2 and 2/2 groups (42–46%).
Table 1 shows the genotypes of oocytes/early embryos obtained
from Shb +/2 oocytes in vitro fertilized with wild-type sperm. The
transmission ratio distortion was again observed with a relative
increase in the number of oocytes carrying the mutated allele, but
the wild-type allele was preferentially present in the embryos
reaching the morula stage compared with those retarded at the 2–
8 cell stage.
The characterization of early embryo development in vitro was
extended further by analysis of blastocyst morphology at 3.5 dpc
(Fig. 7). An increased proportion of blastocysts from the Shb
knockout were less mature (the blastocoele was smaller or not
present), they showed abnormalities in the inner cell mass with
intercellular spaces between cells and abnormalities in the
trophoectoderm with thickened and bulging cells. The genotype
of the embryo was primarily responsible for these abnormalities,
and no difference in the characteristics of oocytes from Shb +/+
or 2/2 mothers was observed, suggesting that Shb is required for
early embryonic development as well.
Taken together, the data in Figs. 6–7 suggest impaired early
embryonic development as a consequence of Shb deficiency.
Figure 1. Number of primary oocytes and relative degree of maturation in fetal ovaries (18.5 dpc). Ovaries were subjected to
morphological analysis determining oocytes in the pachytene and diplotene stages. Representative images of oocytes and ovaries are included in the
figure (scale bar indicates 100 mm). Values are for four genotypes including Shb +/2 (wild-type mother) and Shb 2/+ (wild-type father). Means 6 SEM
for n=5 (+/2 and 2/+) and n=10 (+/+ and 2/2) ovaries. *, ** and *** indicate p,0.05, 0.01 and 0.001, respectively, compared with wild-type control
by ANOVA (Fisher LSD test).
doi:10.1371/journal.pone.0011155.g001
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SHB is a multifunctional adaptor protein potentially affecting
numerous signaling pathways which were investigated in postnatal
ovaries to obtain a mechanistic explanation for the alterations in
follicle and oocyte development observed. Expression of p-
ribosomal protein (rp) S6 (Ser235/236), total rpS6, p-Akt
(Ser473), total Akt, p-ERK (Thr202/Tyr204), total ERK,
p90RSK (Thr573) and total RSK1/RSK2/RSK3 was determined
by Western blot analysis. There was no effect on Akt phosphory-
lation (Fig. 8), but ERK was activated in the absence of SHB. Since
RSK (p90) is a kinase downstream of ERK this protein could be
activated in response to ERK activation, as indeed it appeared from
phosphorylation at an activating site (Fig. 8). RpS6 is one of the
targets of the RSK kinase and since rpS6 phosphorylation
previously was found tocorrelate with premature oocyte maturation
phosphorylation of this protein was also studied. Interestingly, rpS6
phosphorylation was augmented in the absence of SHB, suggesting
stimulation of the ERK-RSK-rpS6 signaling pathway.
The SHB-dependent alterations in oocyte signaling are likely to
contribute to the reproductive aberrations presently observed.
Discussion
Evidence presented above shows that absence of SHB has
significant effects on follicle development and/or oocyte matura-
tion. Whereas SHB depletion promotes early oocyte development,
its absence retards oocyte maturation in the adult. This divergent
action is consistent with the pleiotropic nature of SHB as an
adapter protein participating in numerous responses [8]. In
addition, most of the present findings do not distinguish between
systemic, ovarian or cell autonomous effects and this might
contribute to the diversity of the responses. Shb-null pups have an
increased weight which might have an impact on the develop-
mental stage of the ovaries. However, it seems unlikely that this is
the sole explanation for the observed accelerated oocyte
differentiation for several reasons. Firstly, the effects were
reproduced in organ culture, reducing the influence of systemic
factors. Secondly, the mother’s genotype (+/+ or 2/2) played no
role for the outcome of maturation in the heterozygote fetuses.
Finally, the number of oocytes was increased in the knockout both
before and after birth, thus suggesting that the process of
generating primary oocytes is intrinsically enhanced by the
absence of SHB and thus not related to maturity as such.
In adult ovaries, the absence of Shb exerts detrimental effects on
follicle maturation with a relative reduction in the number of
antral follicles and this could be the consequence of an action of
SHB in germ and/or somatic cells. Follicle maturation is a
consequence of an intricate interplay between granulosa/cumulus
cells and the oocyte where granulosa/cumulus cells stimulate
oocyte growth by producing the c-Kit ligand [20,21], and the
oocyte reciprocates by releasing growth differentiation factor 9 and
bone morphogenic protein 15 [6,22,23]. In addition, c-Kit
signaling has been shown to play a role in primordial germ cell
migration, proliferation and survival [24,25]. It is currently
unknown whether signaling from the c-Kit tyrosine kinase
receptor involves SHB, but it is possible that absence of SHB
may perturb the signaling response in this context, thus retarding
oocyte growth. The present data do not directly address the issue
whether ovulation is affected by Shb gene inactivation or not.
Meiosis I will be completed around this stage, and the loss of
appropriate synchronization of meiosis I reentry and subsequent
polar body extrusion could suggest some abnormality at this stage
as well, although explanations not directly involving ovulation may
also account for the observed aberrations.
Figure 2. Follicle development of 18.5 dpc fetal ovaries from
Shb +/+ and Shb 2/2 mice after culture for 7 days. Fetal ovaries
were cultured for 7 days and the organ explants morphology examined.
Representative images are included in the figure (scale bar indicates
100 mm). Means 6 SEM are given for n=6–8. ** and *** indicate p,0.01
and ,0.001, respectively compared with Shb +/+ using a Student’s t-
test or a Mann-Whitney rank sum test.
doi:10.1371/journal.pone.0011155.g002
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distortion of the Shb-null allele in oocytes from +/2 females. The
precise mechanisms remain unresolved, but probably relate to the
loss of synchronization of meiosis I completion and the behavior of
oocytes in immediate succession of this process.
It should also be noted that some of the effects of Shb deficiency
on oocyte development are observed in mice carrying the
heterozygous mutation. The vascular phenotype was similarly
present in the absence of one Shb allele and it is thus apparent
that haploinsufficiency characterizes certain responses to Shb
mutations.
In isolated oocytes, abnormal signaling was observed, indicating
t h a tt h ea b s e n c eo fS H Bw i l lh a v ed i r e c te f f e c t so no o c y t ef u n c t i o n .
Enhanced ERK and RSK activity was observed in isolated oocytes
and this was paralleled with increased rpS6 phosphorylation. RSK is
one of the many kinases that can phosphorylate rpS6 and since RSK
is downstream of ERK, a plausible signaling pathway that is
operating in the absence of SHB is ERK/RSK/rpS6. In a recent
paper, PTEN ablation caused premature activation of the primordial
follicle pool,due to enhanced Akt signaling and rpS6phosphorylation
[7]. We did not observe in the present study any effect of Shb
deficiency on Akt-activation, and thus the alternative ERK/RSK
signaling scheme seems more likely to account for the increased rpS6
phosphorylation. Absence of Shb s h o w sap h e n o t y p et h a ti sc l e a r l y
distinct from PTEN deficiency, but two similarities are apparent.
B o t hc a u s ep r e m a t u r eo v a r i a nd e v e l o p m e n ta n di nb o t hi n c r e a s e d
Figure 3. Number of primordial, primary and antral follicles from Shb+/+, Shb+/2 and Shb2/2 female mice at 1, 6 and 12 weeks of
age. Morphological analysis of ovaries at the different ages. Representative images are included (scale bars to the left indicate 50 mm). Values are
means 6 SEM (n=10 except +/+ at week 1 where n=7). * denotes a p,0.05; ** p,0.01; *** p,0.001 comparing Shb 2/2 with +/+ using ANOVA
(Fisher LSD test at one and 12 weeks and Kruskal-Wallis variance on ranks at six weeks) or +/2 primordial follicles at 12 weeks with +/+ (Kruskal-Wallis
variance on ranks).
doi:10.1371/journal.pone.0011155.g003
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knockoutaremoremoderate,andthiscouldrelatetotheactivationof
the alternate (ERK/RSK) signaling pathway causing a moderate
increase in rpS6 phosphorylation,contrary tothePTEN-deficiency in
which dramatic effects were observed.
One possibility is that absence of SHB will influence basal
signaling activity without affecting the response to ligand
activation. This is in agreement with a previous study on
endothelial cells isolated from Shb knockout mice in which
increased basal ERK, focal adhesion kinase and p38 MAPK
activity was noted [17]. Completion of meiosis requires ERK
activity [26], but the relationship between ERK-signaling and
meiosis I is less apparent. However, several recent publications
suggest that ERK-activation is involved in the resumption of
meiosis I [27,28,29]. It is therefore likely that increased basal
ERK-activity is related to the unsynchronized pattern of polar
body extrusion in SHB-depleted oocytes. In addition, Src-family
kinases have been shown to exert an influence on meiosis I and II
in mouse oocytes [30]. SHB has previously been found to interact
with Src-family kinases [8], and loss of such an interaction might
contribute to the presently observed abnormalities.
Abnormal blastocyst morphology in Shb 2/2 embryos was
observed and this could hamper efficient implantation and further
embryo development. Considering that no Shb 2/2 mice were
born on the C57Bl/6 background, it seems likely that the
morphological aberrations of Shb knockout blastocysts are more
severe in this strain of mice. The defects in blastocyst morphology
presently observed appear to be related to the genotype of the
embryo rather than to the genotype of the egg. Thus, despite the
abnormalities in oocyte maturation, the oocytes that ovulate and
become fertilized seem to harbor no intrinsic deficiency.
The impairments presently observed are quantitative rather
than absolute since Shb 2/2 mice are able to reproduce on a
mixed genetic background (FVB/J-C57Bl/6-129Sv). This raises
the possibility that the signaling defects presently noted might have
clinical relevance and it might be worthwhile genetically screening
patients with comparable reproductive disorders. We can also infer
that interfering with SHB signaling is a potential strategy for
manipulating oocyte maturation with a view to enhancing or
controlling fertility.
Materials and Methods
Animals
The Shb knockout mouse was generated, maintained on a mixed
genetic background (FVB/N, C57BL/6 and 129/SvJ) and
genotyped as described [16]. Shb +/2 offspring was obtained by
mating wild-type mothers with knockout fathers and the converse
applied to the Shb 2/+ offspring. The animals were housed under
controlled lighting (photoperiod 06:00 to 18:00 h) and provided
with commercial food pellets and tap water ad libitum. The
experiments were approved by the animal ethics committee of
Uppsala University (approval number C44/9).
Follicle numbers in adult ovaries
Ovaries from Shb+/+, Shb+/2 and Shb2/2 female mice were
collected at random stages of the estrous cycle after euthanasia at
ages 1, 6 and 12 weeks (n=5–10 per group). They were fixed for
24 h in Bouin’s fixative, embedded in paraffin wax, sectioned at
5 mm and stained with hematoxylin and eosin. The follicles were
counted in every tenth section using the oocyte nucleus as a marker
and classified according to the shape and number of layers of
somatic cells surrounding the oocyte [31]. Primordial follicles had a
small oocyte with flattened pregranulosa cells, primary follicles had
a growing oocyte with one layer of cuboidal cells, secondary follicles
had multiple layers of granulosa cells and antral follicles contained
an antral cavity. For counting primordial follicles Abercrombie’s
formula wasused to correct forovercounting [32].Ovarianvolumes
were determined on embedded and serially sectioned ovaries. For
Figure 4. Extrusion of polar body after superovulation.
Percentage oocytes with total polar bodies (fresh and degenerated)
at 14 h after hCG injection, as well as fresh and degenerated polar
bodies at 14 and 24 h after hCG injection are given as means 6 SEM for
four to five mice. * and *** indicate p,0.05 and 0.001, for Shb +/+ and
Shb 2/2 oocytes, respectively, using a Student’s t-test. Scale bar
indicates 50 mm.
doi:10.1371/journal.pone.0011155.g004
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geometrical center of the ovary was chosen to measure the major
and minor axis of that structure. The z-value was calculated in
accordance with the number of sections (each 5 mm) from the
beginning of the ovary to that section. The volume was then
calculated assuming an ellipsoid structure according to the formula
4p/3*(minor axis/2)*(major axis/2)*(z).
Fetal oocyte numbers
Fetuses 18.5 days post conception (dpc) were generated in which
the day of mating (vaginal plug) was recorded as 0.5 dpc. On
18.5 dpc the gravid mice were killed and ovaries were dissected
from female fetuses for counting the number of oocytes or for
ovarian culture. Ovaries from five fetuses for four different Shb
genotypes (Shb+/+, Shb+/2, Shb2/+ and Shb2/2) were collected
and the oocytes were counted in 5 mm sections (prepared as
above), scoring diplotene and pachytene stages separately [33].
Ovarian culture- Ovaries from 18.5 dpc fetuses were cut into
quadarants of approximately equal size for culture on Millicell-
CM Biopore membranes (pore size 0.4 mm, Millipore, Billerica,
MA) in DMEM:HAM-F12 (1:1) (Gibco, Grand Island, NY)
supplemented with 15 mM HEPES and 80 mg/ml gentamicin
(Gibco, Grand Island, NY) as previously described [34,35]. The
membrane inserts floated on 0.3 ml of culture medium in 24-well
tissue culture plates (Nunc, Roskilde, Denmark) cultured at 37uC,
5% CO2. The medium was changed every 24 h and cultures
continued for 7 days. Afterwards the ovaries were fixed in Bouin’s
fixative for 1 h, dehydrated and paraffin-embedded for sectioning
and staining.
Mature oocyte analyses and in vitro fertilization (IVF)
Mice 6–12 weeks old were stimulated with 5 IU of pregnant
mares’ gonadotropin (PMSG, Folligon; Intervet, The Netherlands)
intraperitoneally (i.p.). Within 46–48 h after PMSG injection,
Figure 5. Oocyte maturation and chromosome karyotyping. Oocytes were mechanically recovered from ovaries 42 h after PMSG injection
followed by culture for 2, 8, 16, 26 and 40 h. In A, the number of retrieved oocytes is given. B shows polar body extrusion. C depicts the percentage of
oocytes in the GV (germinal vesicle) stage and D the corresponding GVBD (germinal vesicle breakdown) values. E shows the quantification of
chromosomal characteristics after karyotyping at the GVBD stage and F provides representative images of such chromosomal preparations. Means 6
SEM per mouse for n=15 in A are given. In B, n=11 at 2 h, n=6 at 26 hours and n=3 at 16 and 40 h. * and *** indicate p,0.05 and p,0.001,
respectively, when compared with wild-type control using a Wilcoxon signed rank test. In C and D, means 6 SEM for n=11 at 8 hours and n=5 at
26 hours. * and ** indicate p,0.05 and 0.01, respectively compared with wild-type control using a paired t-test. In E, the number of oocytes
karyotyped from 5 separate experiments is given, including those in metaphase MI and pre-metaphase MI. * indicates p,0.05 when compared with
wild-type control using a Chi-square test. Scale bar indicates 10 mm.
doi:10.1371/journal.pone.0011155.g005
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chorionic gonadotropin, i.p. (hCG; Pregnyl; Organon, The
Netherlands). Mice were sacrificed 14–24 h later for collecting
oocytes from the oviducts in M2 Media (Sigma-Aldrich, Sweden
AB). The oocytes were scored for polar body extrusion at 14 and
24 h after hCG.
Another group of mice the same age was injected i.p. only with
5 IU of PMSG and killed 42 h later for harvesting oocytes from
the ovaries using the point of a scalpel to incise the tissue to make
pieces ,1m m
3 [36]. This procedure generates oocytes devoid of
cumulus cells, which is a prerequisite for accurately scoring polar
body extrusion and oocyte progression to the germinal vesicle
breakdown (GVBD) stage. No apparent morphological differences
besides the presence of first polar body were noticed between the
different genotypes at this stage. The oocytes were washed in M2
medium and those that looked healthy, shiny and spherical were
transferred to a drop of M16 medium (Sigma-Aldrich, Sweden
AB) covered with mineral oil in which they were cultured for 2, 8,
16, 26 or 40 h. GVBD and first polar body extrusion were scored
[36]. To prepare metaphase I stages, oocytes were cultured for
5.0–5.5 h and then treated with 0.3% sodium citrate for 30 min
Figure 6. Embryo development after in vitro fertilization.
Fertilized oocytes developing to the morula stage and those
undergoing degeneration were scored as percentages in each group
of collected oocytes. Means 6 SEM in four separate experiments are
given. * and ** indicate p,0.05 and 0.01, respectively when compared
with wild-type control using a paired Student’s t-test.
doi:10.1371/journal.pone.0011155.g006
Table 1. The genotype ratio was distorted after IVF with
oocytes from Shb +/2 mothers and Shb +/+ sperm.
Stage Shb +/+ Shb +/2
2–8 cell stage 1* (7%) 13 (93%)
Morula 9 (36%) 16 (64%)
Unfertilized 15 (31%) 34 (69%)
Degenerated 7 (21%) 27 (79%)
Oocytes from +/2 mothers were isolated, in vitro fertilized with +/+ sperm and
differentiated in vitro as in Fig. 6. At 24 h after IVF the early embryos/oocytes
were classified and genotyped. The absolute and relative (in percent) +/+ vs
+/2 embryos/oocytes are given for each category. * indicates p,0.05 when
compared with the corresponding number of morulas using the Chi-square
test. The total percentage +/+ genotype was 26% for 122 observations.
doi:10.1371/journal.pone.0011155.t001
Figure 7. Blastocyst morphology at 3.5 dpc. Percentage abnormal
embryos was determined in each litter and expressed as means 6 SEM
for five experiments. +/2 is wild-type mother and 2/+ is wild-type
father. ** indicates p,0.01 when compared with wild-type control
using Student’s t-test with Bonferroni correction. A shows wild-type
blastocyst, B-E Shb 2/2 blastocysts. Scale bar indicates 100 mm.
doi:10.1371/journal.pone.0011155.g007
SHB and Oocyte Maturation
PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e11155and fixed with freshly prepared methanol: acetic acid (3:1). Fixed
oocytes were stained with Giemsa solution for 1 min, washed and
dried in air for visualizing chromosomes.
For IVF were female mice aged 4–6 weeks of three genotypes
(n=2 per group for each experiment, ie Shb+/+, Shb+/2, Shb2/2)
injected with 5 IU of PMSG followed by hCG, as described above.
They were sacrificed 14 h after the second injection and oocytes
with associated cumulus cells were harvested from the oviducts in
DMEM Medium. Shortly before sperm was isolated from the
epididymides and the vas deferentia from a Shb+/+ male mouse
and incubated for 10 min before aliquoted to fertilization dishes
(see http://cryo.jax.org/ivf.html for details of method). IVF was
done in DMEM medium and after 4 h incubation, the eggs were
washed to remove excess sperm and transferred to microdrops of
50 ml embryo culture medium (KSOM) containing 20 fertilized
oocytes for an additional 24 h culture period under oil allowing
differentiation to the morula stage.
Blastocyst analysis
Blastocysts from four different breeding groups (Shb+/+, Shb+/2,
Shb2/+, Shb2/2) were collected on 3.5 dpc from the uteri of
females 6 to 12 weeks old mated with a male of the appropriate
genotype. The blastocysts were examined briefly before fixing
overnight in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer
(pH=7.2). They were rinsed in the same buffer, stained with
1% osmium tetroxide, dehydrated in graded alcohols and
embedded separately in plastic for sectioning at 3 mma n ds t a i n e d
with toluidine blue.
Western Blot analysis
Ovaries were digested at 37uC in a collagenase A solution (2%,
w/v) for 30–60 min (according to rates of follicle release) yielding
500–600 oocytes which were collected in SDS sample buffer and
heated for 5 min at 100uC [7]. The proteins were separated by
SDS-PAGE and then transferred to Hybond membranes which
were blocked in TBS+0.1% Tween 20 supplemented with 5%
BSA for 4 h. The membranes were incubated overnight at 4uC
with one of nine primary antibodies at 1:1000. The antibodies
were phospho-S6 ribosomal protein (Ser235/236) (Cell Signaling
Technology, USA), ribosomal protein S6 (C-8) (Santa Cruz
Biotechnology, USA), phospho-Akt (ser473), total Akt, phospho-
p90RSK (Thr573), total RSK1/RSK2/RSK3, phospho-ERK,
total ERK and b-actin. After washing in TBS+0.1% Tween 20 the
membranes were incubated for 1 h at room temperature with
1:1000 HRP-conjugated goat anti-rabbit IgG or HRP-conjugated
goat anti-mouse IgG. They were processed using the chemilumi-
nescence (ECL+) detection system (GE Healthcare, Uppsala,
Sweden).
Statistical analysis
Statistical comparisons were made between groups including
both parametric and non-parametric tests as stated in the legends
to the figures. Non-parametric tests were used when the
populations or differences were not normally distributed.
Supporting Information
Figure S1 Ratio primary/primordial at 1, 6 and 12 weeks of age
and ratio antral/primordial at 6 and 12 weeks. Means 6 SEM are
given for the same number of observations as in Fig. 1. * p,0.05;
** p,0.01; *** p,0.001 using a Students’ t-test.
Found at: doi:10.1371/journal.pone.0011155.s001 (2.25 MB TIF)
Table S1 Female mouse weights and ovarian volumes of the
different genotypes as indicated at the given ages.
Found at: doi:10.1371/journal.pone.0011155.s002 (0.03 MB
DOC)
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Figure 8. Akt, ERK, RSK and rpS6 activities/phosphorylation. Oocytes were isolated from neonatal Shb +/+ and 2/2 mice and subjected to
Western blot analysis. Phosphorylation was related to total protein content on the same blot and determined by densitometric analysis. Values are
arbitrary units expressed as means 6 SEM. n=3 for RSK, n=4 for Akt, n=5 for ERK and n=6 for rpS6. * and ** indicate p,0.05 and 0.01, respectively
using a paired t-test.
doi:10.1371/journal.pone.0011155.g008
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